Collaborating to Advance Angelman Syndrome Research
FAST’s Scientific Advisory Board brings together scientists and clinicians with expertise spanning Angelman syndrome, genetics, neuroscience, therapeutic development, clinical research, outcome measurement, and related disciplines.
Led by Scientific Advisory Board Chair Dr. Barbara Bailus, the SAB helps guide FAST’s scientific strategy, reviews research proposals, and provides independent scientific perspective on emerging opportunities and ongoing programs.
Barbara Bailus, PhD Scientific Advisory Board Chair
Assistant Professor of Genetics
Keck Graduate Institute, The Claremont Colleges
Scientific Advisory Board Members
President
Brett Abrahams, PhD
Heppinn Biosciences
Neuroscience, genetics, and drug development
Professor, Departments of Pediatrics, Neurology, and Neurosciences
Anne Anderson, MD
Baylor College of Medicine
Pediatric epilepsy and clinical neurophysiology
University Professor and Hospital Practitioner
Nadia Bahi-Buisson, PhD
Neuropediatrics Department, CHU Necker Enfants-Malades
Pediatric neurology and neurodevelopmental disorders
Professor, Newborn Screening Laboratory
Mei Baker, MD, FACMG
University of Wisconsin School of Medicine and Public Health
Newborn screening and biochemical and molecular genetics
Professor
Marisa Bartolomei, PhD
University of Pennsylvania
Perelman School of Medicine
Genomic imprinting and epigenetics
Founder and CEO
Art Beaudet, MD
Luna Genetics
Human genetics and genomic medicine
Professor of Pediatrics, Neurological Sciences, Anatomy and Cell Biology
Elizabeth Berry-Kravis, MD, PhD
Rush University Medical Center
Angelman syndrome, clinical research, and therapeutic development
Distinguished Scientist
Lauren E. Black, PhD
Charles River Laboratories
Preclinical development and translational research
Professor
Robert Carson, MD, PhD
Monroe Carell Jr. Children’s Hospital at Vanderbilt
Pediatric neurology, epilepsy, and Angelman syndrome
Vice President, Program Development and Medical Insights / Head of Neurology and Cell & Gene Therapy Centers of Excellence
Jimmy El Hokayem, PhD
Biorasi
Clinical development, neurology, and cell and gene therapy
Assistant Adjunct Professor, Department of Neurology
Kyle Fink, PhD
University of California, Davis
Gene-modifying therapeutics and translational neuroscience
Professor of Genetics, Neuroscience, and Pediatrics and Chief of Medical Genetics
Yong-Hui Jiang, MD, PhD
Yale School of Medicine / Yale New Haven Hospital
Human genetics, neuroscience, and Angelman syndrome
Goodnight Distinguished Scholar and Associate Professor
Albert Keung, PhD
North Carolina State University
Synthetic biology, neuroepigenetics, and disease modeling
Professor and Director, Center for Neural Science
Eric Klann, PhD
Associate Professor
Kevin Nash, PhD
University of South Florida
AAV biology, gene delivery, and neurological disorders
Developmental-Behavioral Pediatrician
Cesar Ochoa-Lubinoff, MD, PhD
Cedars-Sinai Medical Center
Developmental-behavioral pediatrics and neurodevelopmental disorders
Professor
Bryce B. Reeve, PhD
Duke University School of Medicine
Outcome measurement, psychometrics, and patient-centered research
Professor
David Segal, PhD
University of California, Davis
Genomic therapeutics, gene editing, and epigenome editing
Professor of Paediatric Neuromuscular Diseases
Laurent Servais, MD, PhD
North Carolina State University
Synthetic biology, neuroepigenetics, and disease modeling
Director of Preclinical Development
Keith Sutton, PhD
Resolution Therapeutics
Preclinical and translational development of advanced therapeutics
CEO and Chief Scientific Officer
Ashley Winslow, PhD
Odylia Therapeutics
Rare disease drug development and translational science
Neurogeneticist
Tim Yu, MD, PhD
Boston Children’s Hospital / Harvard Medical School
Neurogenetics, genomic medicine, and individualized therapeutics
Professor of Paediatric Neurogenetics
Stephan Sanders, PhD
University of Oxford / University of California, San Francisco / NY Genome Center
Neurodevelopmental disorders, genomics, neurobiology, and therapeutics
Guidance for Researchers Entering the Field
For researchers considering a career in Angelman syndrome research, FAST’s Scientific Advisory Board represents an exceptionally supportive and collaborative community. Early-career scientists and investigators new to the field are encouraged to connect with more experienced researchers for guidance, mentorship, and perspective. Our senior scientists have navigated the challenges of building a research career, and they are eager to help the next generation succeed in advancing the field.
Additional Scientific Expertise
FAST may also engage additional scientific experts when specialized expertise or independent review is needed to evaluate a research opportunity.